Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study

被引：0
|
作者：
Citrome, L. [1 ]
Ota, A. [2 ]
Nagamizu, K. [2 ]
Perry, P. [3 ]
Weiller, E.
Baker, R. [4 ]
机构：
[1] New York Med Coll, Psychiat & Behav Sci, Suffern, NY USA
[2] Otsuka Pharmaceut Co Ltd, CNS, Tokyo, Japan
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Clin Management, Princeton, NJ USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30711-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.063
引用
收藏
页码：S516 / S517
页数：2
相关论文
共 50 条
  • [41] Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study
    Baker, R.
    Jin, N.
    Weiller, E.
    Weiss, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S952 - S952
  • [42] An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction
    Eardley, I
    Wright, P
    Macdonagh, R
    Hole, J
    Edwards, A
    BJU INTERNATIONAL, 2004, 93 (09) : 1271 - 1275
  • [43] Prevalence of diabetes/cardiovascular risk factors among schizophrenia patients treated with atypical antipsychotics in a multicenter, randomized, naturalistic, open-label study (Schizophrenia Trial of Aripiprazole: STAR study)
    Litalien, Gilbert J.
    Blonde, Lawrence
    Hanssens, Linda
    McQuade, Robert
    DIABETES, 2006, 55 : A538 - A538
  • [44] An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
    Si, TianMei
    Tan, QingRong
    Zhang, KeRang
    Wang, Yang
    Rui, Qing
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 87 - 95
  • [45] A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
    Takekita, Yoshiteru
    Kato, Masaki
    Wakeno, Masataka
    Sakai, Shiho
    Suwa, Azusa
    Nishida, Keiichiro
    Okugawa, Gaku
    Kinoshita, Toshihiko
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 110 - 114
  • [46] Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study
    Adamo, Daniela
    Pecoraro, Giuseppe
    Aria, Massimo
    Favia, Gianfranco
    Mignogna, Michele Davide
    PAIN MEDICINE, 2020, 21 (01) : 185 - 194
  • [47] Patient-Optimized Doses of Fesoterodine Improve Bladder Symptoms in an Open-Label, Flexible-Dose Study Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2011, 186 (03): : 994 - 995
  • [48] Efficacy of Solifenacin in Patients Previously Treated with Tolterodine Extended Release 4 mg: Results of a 12-Week, Multicenter, Open-Label, Flexible-Dose Study
    Chancellor, Michael B.
    Zinner, Norman
    Whitmore, Kristene
    Kobashi, Kathleen
    Snyder, Jeffrey A.
    Siami, Paul
    Karram, Mickey
    Laramee, Christine
    Capo', James R., Jr.
    Seifeldin, Raafat
    Forero-Schwanhaeuser, Sergio
    Nandy, Indrani
    CLINICAL THERAPEUTICS, 2008, 30 (10) : 1766 - 1781
  • [49] Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: A 12-week open-label, multicenter trial
    Mirone, V
    Palmieri, A
    Cucinotta, D
    Parazzini, F
    Morelli, P
    Bettocchi, C
    Fusco, F
    Montorsi, F
    JOURNAL OF SEXUAL MEDICINE, 2005, 2 (06): : 842 - 847
  • [50] Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: Multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase
    Kadioglu, Ates
    Grohmann, Walther
    Depko, Andrzej
    Levinson, Ivan P.
    Sun, Franklin
    Collins, Suzanne
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (03): : 726 - 734
12345